A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
scientific article published on 23 February 2017
Author/s
author: Allison C Rosenthal, Amylou Dueck, Rodger Tiedemann, Thomas E. Witzig, Morie A Gertz, Francis K Buadi, Shaji K Kumar, David Dingli, Stephen M Ansell, Luis F Porrata, Grzegorz S Nowakowski, Craig B Reeder, Stephen J. Russell, Joseph P. Colgan, John K Camoriano, David J. Inwards-Breland, Prashant Kapoor
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.